The same study reported that inhibitors of PERK (GSK2656157) or IRE1α (4μ8C), or, alternatively, genetic deletion of PERK or IRE1α, significantly prevented overexpression of these inflammatory cytokines in 786-O RCC cells [47]. This evidence concerns the gene EIF2AK3 and renal cell carcinoma.